Casgevy gains UK label expansion for younger patient population Pharmaceutical Technology 14:33 Fri, 30 Oct
Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More The Motley Fool 23:12 Sat, 24 Oct
UCLA advances CRISPR gene-editing therapy for sickle cell disease News-Medical.Net 3d UCLA Genetics Biology
Casgevy gains UK label expansion for younger patient population Pharmaceutical Technology 14:33 Fri, 30 Oct Casgevy CRISPR Therapeutics Pharma All sources
From gene editing to RNA therapies: The biotech trends to look out for at AHA Scientific Sessions 2026 Labiotech 3d Biotech Biotechnology Pharma
Custom gene-Editing therapies for rare diseases could win faster approvals under FDA draft plan, not yet final Medical Daily 8d Rare Diseases Pennsylvania Health
ANI to expand its rare disease portfolio with Egetis takeout Scrip Pharma Intelligence 2d FDA Rare Diseases
6 biotech stocks for a volatile bull market: Jon Erlichman BNN Bloomberg 1d Bull Market Biotechnology
CBI FIR against waste management company Hanjer Biotech for defrauding bank of $10 million under guise of setting up recycling plant in UK; 2nd fraud case The Times of India 1d Biotech Mumbai India
